Among the stock activity stories for Monday, June 24, from AP Business News:
— Rovi Corp.'s shares dropped after a Pacific Crest Securities analyst downgraded his rating on digital TV listings company, citing concerns about limited growth potential.
— Shares of drug developer Allergan Inc. sank on the first full trading day after the Food and Drug Administration released a draft of guidance that could provide an easier-than-expected path to approval for a generic challenger to its eye treatment Restasis.
- Investment & Company Information
- Food and Drug Administration